U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C25H24N3O8S2.Na
Molecular Weight 581.593
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AGN-201904-Z

SMILES

[Na+].COC1=CC=C2N(C(=NC2=C1)[S+]([O-])CC3=C(C)C(OC)=C(C)C=N3)S(=O)(=O)C4=CC=C(OCC([O-])=O)C=C4

InChI

InChIKey=VHTOWLOOYYGTNQ-UHFFFAOYSA-M
InChI=1S/C25H25N3O8S2.Na/c1-15-12-26-21(16(2)24(15)35-4)14-37(31)25-27-20-11-18(34-3)7-10-22(20)28(25)38(32,33)19-8-5-17(6-9-19)36-13-23(29)30;/h5-12H,13-14H2,1-4H3,(H,29,30);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C25H24N3O8S2
Molecular Weight 558.603
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Allergan was developing the proton pump inhibitor AGN-201904 as an enteric-coated formulation for the treatment of gastric ulcer disease. AGN-201904 is a slowly absorbed, acid-stable pro-proton pump inhibitor (pro-PPI) rapidly converted to omeprazole in the systemic circulation giving a prolonged residence time. AGN-201904 has been used in trials studying the prevention of peptic ulcer.

Approval Year

PubMed

PubMed

TitleDatePubMed
Gateways to clinical trials.
2007 Sep
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
2008 Jul
Patents

Sample Use Guides

AGN-201904 enteric-coated capsules (600 mg/day) or esomeprazole delayed-release tablets (40 mg/day) were administered for 5 days.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:55:24 GMT 2023
Edited
by admin
on Fri Dec 15 15:55:24 GMT 2023
Record UNII
14Y11U7IYM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AGN-201904-Z
Common Name English
(4-((5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOL-1-YL)SULFONYL)PHENOXY)ACETIC ACID, SODIUM SALT
Common Name English
ALEVIUM
Common Name English
(4-((5-METHOXY-2-(4-METHOXY-3,5-DIMETHYL-PYRIDIN-2-YLMETHANESULFINYL)-BENZOIMIDAZOLE-1-SULFONYL)-PHENOXY)-ACETIC ACID, SODIUM SALT
Common Name English
Code System Code Type Description
PUBCHEM
23672767
Created by admin on Fri Dec 15 15:55:24 GMT 2023 , Edited by admin on Fri Dec 15 15:55:24 GMT 2023
PRIMARY
CAS
651728-41-5
Created by admin on Fri Dec 15 15:55:24 GMT 2023 , Edited by admin on Fri Dec 15 15:55:24 GMT 2023
PRIMARY
FDA UNII
14Y11U7IYM
Created by admin on Fri Dec 15 15:55:24 GMT 2023 , Edited by admin on Fri Dec 15 15:55:24 GMT 2023
PRIMARY
EPA CompTox
DTXSID40983747
Created by admin on Fri Dec 15 15:55:24 GMT 2023 , Edited by admin on Fri Dec 15 15:55:24 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE